What is a stock summary page? Click here for an overview.
Business Description
Alaunos Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US98973P1012
Share Class Description:
TCRT: Ordinary SharesDescription
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.77 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -371.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -72.4 | |||||
| 3-Year EPS without NRI Growth Rate | -69.1 | |||||
| 3-Year FCF Growth Rate | -81.1 | |||||
| 3-Year Book Growth Rate | -64.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 89.73 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.93 | |||||
| 9-Day RSI | 62.29 | |||||
| 14-Day RSI | 54.81 | |||||
| 3-1 Month Momentum % | -16.69 | |||||
| 6-1 Month Momentum % | -58.56 | |||||
| 12-1 Month Momentum % | -91.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | |||||
| Quick Ratio | 4.3 | |||||
| Cash Ratio | 2.04 | |||||
| Days Sales Outstanding | 152.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -123633.33 | |||||
| Net Margin % | -196350 | |||||
| FCF Margin % | -196066.67 | |||||
| ROE % | -187.01 | |||||
| ROA % | -140.36 | |||||
| ROIC % | -364.81 | |||||
| 3-Year ROIIC % | -264.84 | |||||
| ROC (Joel Greenblatt) % | -600.03 | |||||
| ROCE % | -182.01 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 402.68 | |||||
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 0.95 | |||||
| EV-to-EBIT | 0.31 | |||||
| EV-to-EBITDA | 0.32 | |||||
| EV-to-Revenue | -615.33 | |||||
| EV-to-Forward-Revenue | 4293.85 | |||||
| EV-to-FCF | 0.31 | |||||
| Price-to-GF-Value | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 0.95 | |||||
| Price-to-Net-Cash | 2.98 | |||||
| Earnings Yield (Greenblatt) % | 322.58 | |||||
| FCF Yield % | -456.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TCRT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alaunos Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.006 | ||
| EPS (TTM) ($) | -7.408 | ||
| Beta | -1.52 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.65 | ||
| Volatility % | 79.19 | ||
| 14-Day RSI | 54.81 | ||
| 14-Day ATR ($) | 0.076513 | ||
| 20-Day SMA ($) | 1.518145 | ||
| 12-1 Month Momentum % | -91.45 | ||
| 52-Week Range ($) | 1.42 - 19.8 | ||
| Shares Outstanding (Mil) | 1.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alaunos Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alaunos Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alaunos Therapeutics Inc Frequently Asked Questions
What is Alaunos Therapeutics Inc(TCRT)'s stock price today?
The current price of TCRT is $1.61. The 52 week high of TCRT is $19.80 and 52 week low is $1.42.
When is next earnings date of Alaunos Therapeutics Inc(TCRT)?
The next earnings date of Alaunos Therapeutics Inc(TCRT) is 2025-05-09 Est..
Does Alaunos Therapeutics Inc(TCRT) pay dividends? If so, how much?
Alaunos Therapeutics Inc(TCRT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers